Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 5
2004 3
2006 1
2009 2
2010 1
2011 2
2012 5
2014 2
2015 1
2017 2
2018 1
2019 1
2021 2
2022 1
2023 5
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

35 results

Results by year

Filters applied: . Clear all
Page 1
Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.
Westin SN, Moore K, Chon HS, Lee JY, Thomes Pepin J, Sundborg M, Shai A, de la Garza J, Nishio S, Gold MA, Wang K, McIntyre K, Tillmanns TD, Blank SV, Liu JH, McCollum M, Contreras Mejia F, Nishikawa T, Pennington K, Novak Z, De Melo AC, Sehouli J, Klasa-Mazurkiewicz D, Papadimitriou C, Gil-Martin M, Brasiuniene B, Donnelly C, Del Rosario PM, Liu X, Van Nieuwenhuysen E; DUO-E Investigators. Westin SN, et al. J Clin Oncol. 2024 Jan 20;42(3):283-299. doi: 10.1200/JCO.23.02132. Epub 2023 Oct 21. J Clin Oncol. 2024. PMID: 37864337 Free PMC article. Clinical Trial.
Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEYNOTE-040): a randomised, open-label, phase 3 study.
Cohen EEW, Soulières D, Le Tourneau C, Dinis J, Licitra L, Ahn MJ, Soria A, Machiels JP, Mach N, Mehra R, Burtness B, Zhang P, Cheng J, Swaby RF, Harrington KJ; KEYNOTE-040 investigators. Cohen EEW, et al. Lancet. 2019 Jan 12;393(10167):156-167. doi: 10.1016/S0140-6736(18)31999-8. Epub 2018 Nov 30. Lancet. 2019. PMID: 30509740 Clinical Trial.
Smartphone sensors for evaluating COVID-19 fear in patients with cancer: a prospective study.
Kasputytė G, Jenciūtė G, Šakinis N, Bunevičienė I, Korobeinikova E, Vaitiekus D, Inčiūra A, Jaruševičius L, Bunevičius R, Krikštolaitis R, Krilavičius T, Juozaitytė E, Bunevičius A. Kasputytė G, et al. Among authors: inciura a. Front Public Health. 2024 Jan 5;11:1308003. doi: 10.3389/fpubh.2023.1308003. eCollection 2023. Front Public Health. 2024. PMID: 38249398 Free PMC article.
[Update on treatment of bladder cancer].
Visockiene R, Inciūra A, Juozaityte E. Visockiene R, et al. Among authors: inciura a. Medicina (Kaunas). 2004;40(12):1239-48. Medicina (Kaunas). 2004. PMID: 15630352 Free article. Review. Lithuanian.
Digital Phenotyping for Monitoring and Disease Trajectory Prediction of Patients With Cancer: Protocol for a Prospective Observational Cohort Study.
Jenciūtė G, Kasputytė G, Bunevičienė I, Korobeinikova E, Vaitiekus D, Inčiūra A, Jaruševičius L, Bunevičius R, Krikštolaitis R, Krilavičius T, Juozaitytė E, Bunevičius A. Jenciūtė G, et al. Among authors: inciura a. JMIR Res Protoc. 2023 Oct 10;12:e49096. doi: 10.2196/49096. JMIR Res Protoc. 2023. PMID: 37815850 Free PMC article.
Primary epithelioid sarcoma of the neck: a rare case report.
Rudžianskas V, Juozaitytė E, Inčiūra A, Sarauskas V, Rudžianskienė M. Rudžianskas V, et al. Among authors: inciura a. Medicina (Kaunas). 2012;48(1):57-60. Epub 2012 Feb 22. Medicina (Kaunas). 2012. PMID: 22370506 Free article.
Reirradiation for patients with recurrence head and neck squamous cell carcinoma: a single-institution comparative study.
Rudžianskas V, Inčiūra A, Vaitkus S, Padervinskis E, Rudžianskienė M, Kupčinskaitė-Noreikienė R, Saltonaitė L, Noreika A, Statnickaitė A, Juozaitytė E. Rudžianskas V, et al. Among authors: inciura a. Medicina (Kaunas). 2014;50(2):92-9. doi: 10.1016/j.medici.2014.06.006. Epub 2014 Jun 28. Medicina (Kaunas). 2014. PMID: 25172603 Free article. Clinical Trial.
Single vs. multiple fraction regimens for palliative radiotherapy treatment of multiple myeloma : A prospective randomised study.
Rudzianskiene M, Inciura A, Gerbutavicius R, Rudzianskas V, Macas A, Simoliuniene R, Dambrauskiene R, Kiavialaitis GE, Juozaityte E. Rudzianskiene M, et al. Among authors: inciura a. Strahlenther Onkol. 2017 Sep;193(9):742-749. doi: 10.1007/s00066-017-1154-5. Epub 2017 Jun 1. Strahlenther Onkol. 2017. PMID: 28573476 Free PMC article. Clinical Trial.
35 results